Mohlo by se vám také líbit

Informovat o naskladnění knihy

Více informací o knize Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

• Parametry knihy
• Anotace
• Oblíbené z jiného soudku

Nákupem získáte 282 bodů

Anotace knihy

Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second edition, comprehensively presents the current knowledge on anemia in cancer and its treatment with rhEPO. Future developments are also discussed. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO. The book, considered as a standard work, will again serve as an essential source of information for radiotherapists, medical oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion and laboratory medicine, and pharmacologists.

Parametry knihy

Zařazení knihy Knihy v angličtině Medicine Clinical & internal medicine Diseases & disorders

• Plný název: Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology
• Podnázev: Scientific and Clinical Aspects of Anemia in Cancer
• Autor: Mohammad R. Nowrousian
• Jazyk: Angličtina
• Vazba: Pevná
• Počet stran: 866
• EAN: 9783211252239
• ISBN: 3211252231
• ID: 05265853
• Nakladatelství: Springer Verlag GmbH
• Hmotnost: 1718 g
• Rozměry: 244 × 170 × 50 mm
• Datum vydání: 19. December 2007

Oblíbené z jiného soudku

---

---

---